tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Bristol-Myers Squibb Co

BMY
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
66.820USD
-1.270-1.87%
์ข…๊ฐ€ย 09-04 16:00๏ผˆET๏ผ‰
136.46B์‹œ๊ฐ€์ด์•ก
18.70P/E TTM

BMY ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Bristol-Myers Squibb Co์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Jul 30, 2026
EPS / ์˜ˆ์ƒ
1.62/1.59
์ˆ˜์ต / ์˜ˆ์ƒ
12.97B/11.75B
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
48.19B
-0.22%
EPS(YoY)
3.47
178.56%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/09/07
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
152.34%1.62
8.62%1.31
1406.65%0.53
81.04%1.08
-22.33%0.64
120.54%1.21
-95.92%0.04
-36.29%0.60
-16.32%0.83
-646.35%-5.89
-9.33%0.87
--0.94
--0.99
--1.08
--0.96
--2.01
----
----
----
----
์ˆ˜์ต
5.74%12.97B
2.57%11.49B
1.30%12.50B
2.77%12.22B
0.56%12.27B
-5.60%11.20B
7.54%12.34B
8.44%11.89B
8.69%12.20B
4.66%11.87B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
-2.67%11.34B
-4.83%11.41B
-3.49%11.22B
1.57%11.89B
5.19%11.65B
8.29%11.98B
10.28%11.62B
์ˆœ์ด์ต
153.21%3.32B
9.00%2.68B
1409.72%1.09B
81.75%2.20B
-22.02%1.31B
120.62%2.46B
-95.91%72.00M
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-14.76%2.02B
3.88%1.61B
34.69%1.42B
-36.76%1.28B
123.66%2.37B
-17.41%1.55B
์ˆœ์ด์ต๋ฅ 
138.85%25.56%
6.05%23.31%
1309.37%8.68%
75.78%17.96%
-22.46%10.70%
121.90%21.98%
-95.99%0.62%
-42.07%10.22%
-25.40%13.80%
-601.90%-100.36%
-13.53%15.35%
--17.64%
--18.50%
--20.00%
--17.75%
--12.43%
----
----
----
----
์ด ์ด์ต๋ฅ 
3.25%68.03%
1.35%66.53%
8.44%65.34%
18.57%66.10%
17.97%65.88%
18.05%65.65%
6.53%60.26%
-1.71%55.75%
2.29%55.85%
-3.25%55.61%
-0.59%56.57%
--56.72%
--54.60%
--57.48%
--56.90%
--57.55%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-5.29%49.20%
-4.41%51.41%
-6.55%50.10%
-4.83%50.55%
-6.15%51.95%
-4.34%53.78%
28.28%53.61%
28.91%53.11%
37.35%55.35%
40.12%56.22%
2.92%41.80%
--41.20%
--40.30%
--40.12%
--40.61%
--39.82%
----
----
----
----
์ˆ˜์ต
5.74%12.97B
2.57%11.49B
1.30%12.50B
2.77%12.22B
0.56%12.27B
-5.60%11.20B
7.54%12.34B
8.44%11.89B
8.69%12.20B
4.66%11.87B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
-2.67%11.34B
-4.83%11.41B
-3.49%11.22B
1.57%11.89B
5.19%11.65B
8.29%11.98B
10.28%11.62B
์˜์—… ์ด์ต
6.33%4.87B
-2.02%3.98B
38.56%4.20B
59.86%4.42B
49.98%4.58B
50.87%4.07B
16.12%3.03B
1.84%2.77B
21.10%3.05B
-10.29%2.69B
2.59%2.61B
-0.77%2.71B
-21.24%2.52B
-5.83%3.00B
-8.75%2.54B
-8.37%2.74B
7.89%3.20B
25.99%3.19B
143.79%2.79B
52.19%2.99B
์ˆœ์ด์ต
153.21%3.32B
9.00%2.68B
1409.72%1.09B
81.75%2.20B
-22.02%1.31B
120.62%2.46B
-95.91%72.00M
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-14.76%2.02B
3.88%1.61B
34.69%1.42B
-36.76%1.28B
123.66%2.37B
-17.41%1.55B
์œ ๋™์ž์‚ฐ
-13.98%28.58B
-11.61%27.21B
-1.31%29.39B
26.91%35.63B
23.55%33.22B
7.37%30.78B
-6.26%29.78B
1.60%28.07B
-4.22%26.89B
5.84%28.67B
16.49%31.77B
3.12%27.63B
-7.00%28.07B
-10.08%27.09B
-18.01%27.27B
-14.78%26.80B
3.51%30.19B
11.10%30.12B
10.17%33.26B
-8.27%31.44B
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-32.22%18.66B
-20.41%19.16B
-1.50%23.42B
24.29%28.14B
18.32%27.53B
-6.78%24.07B
6.79%23.77B
-3.51%22.64B
15.46%23.27B
35.30%25.82B
1.70%22.26B
23.94%23.46B
-3.66%20.15B
-16.37%19.09B
0.10%21.89B
-11.79%18.93B
10.13%20.91B
31.68%22.82B
14.61%21.87B
4.87%21.46B
์ด ์ž์‚ฐ
-7.44%87.63B
-6.44%86.48B
-2.77%90.04B
3.44%96.89B
0.03%94.68B
-6.67%92.43B
-2.69%92.60B
2.64%93.67B
1.24%94.65B
5.04%99.03B
-1.72%95.16B
-7.06%91.26B
-6.84%93.49B
-8.50%94.28B
-11.43%96.82B
-11.45%98.20B
-9.42%100.36B
-8.36%103.03B
-7.74%109.31B
-11.66%110.89B
๋ถ€์ฑ„ ์ด๊ณ„
-15.38%65.31B
-11.48%66.37B
-6.14%71.53B
2.38%78.29B
-0.50%77.19B
-9.10%74.98B
16.05%76.22B
22.94%76.47B
26.23%77.58B
32.19%82.48B
-0.04%65.67B
-4.98%62.20B
-9.21%61.46B
-12.60%62.40B
-10.38%65.70B
-11.07%65.46B
-8.42%67.70B
-4.51%71.39B
-9.05%73.31B
-2.25%73.61B
์ž๋ณธ ์ด๊ณ„
27.62%22.32B
15.21%20.10B
12.92%18.51B
8.14%18.60B
2.46%17.49B
5.44%17.45B
-44.42%16.39B
-40.82%17.20B
-46.71%17.07B
-48.10%16.55B
-5.25%29.48B
-11.22%29.06B
-1.93%32.03B
0.76%31.89B
-13.58%31.12B
-12.20%32.73B
-11.43%32.66B
-16.00%31.64B
-4.95%36.01B
-25.77%37.28B
์ˆœ์˜์—…์ด์ต
-13.38%3.39B
-43.50%1.10B
-55.53%1.97B
12.88%6.31B
68.40%3.92B
-31.05%1.95B
4.40%4.44B
17.68%5.59B
23.26%2.33B
-4.58%2.83B
28.61%4.25B
28.86%4.75B
-16.54%1.89B
-22.09%2.97B
-18.51%3.31B
-29.98%3.69B
-26.11%2.26B
-0.31%3.81B
10.54%4.06B
132.29%5.27B
์ˆœํˆฌ์ž
-241.23%-1.61B
73.75%-131.00M
-643.88%-1.46B
-677.17%-1.70B
64.14%-473.00M
97.46%-499.00M
85.44%-196.00M
46.59%-219.00M
-300.91%-1.32B
-9241.90%-19.62B
-210.96%-1.35B
80.30%-410.00M
-13.84%-329.00M
-321.05%-210.00M
202.49%1.21B
-113.22%-2.08B
-260.56%-289.00M
166.43%95.00M
103.31%401.00M
-358.22%-976.00M
์ˆœ์žฌ๋ฌดํ™œ๋™
-43.25%-2.63B
-57.10%-1.56B
-267.17%-6.03B
61.32%-1.49B
54.36%-1.84B
-106.78%-993.00M
-269.80%-1.64B
25.35%-3.85B
-85.14%-4.02B
580.13%14.64B
129.79%967.00M
-13.58%-5.16B
38.27%-2.17B
46.05%-3.05B
18.17%-3.25B
-155.22%-4.54B
-10.62%-3.52B
22.51%-5.65B
-213.90%-3.97B
31.19%-1.78B

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Bristol-Myers Squibb Co์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 48.19B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 48.30B์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 29.39B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1.31์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Bristol-Myers Squibb Co์˜ ์ด์ž์‚ฐ์€ 90.04B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -2.77์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Bristol-Myers Squibb Co์˜ ์ด๋ถ€์ฑ„๋Š” 71.53B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.14์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Bristol-Myers Squibb Co์˜ ์ด์ž๋ณธ์€ 18.51B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 12.92์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Bristol-Myers Squibb Co์˜ ์ˆœ์˜์—…์†Œ๋“์€ 17.26B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 49.54์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Bristol-Myers Squibb Co์˜ ์ˆœํˆฌ์ž๋Š” -4.13B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 80.65์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Bristol-Myers Squibb Co์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -10.35B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -301.83์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 3.47์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 178.56์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 7.05B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 178.83์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 14.64์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 179.15์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 65.74์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 15.55์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 50.10์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.55์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ 40.53์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 203.65์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 7.73์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 181.19์ž…๋‹ˆ๋‹ค.

Bristol-Myers Squibb Co์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Bristol-Myers Squibb Co์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 17.26B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 49.54์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ